Cargando…
Movement toward Environmentally Friendly Pharmaceuticals in Japan
As an economic activity, any medical practice involves greenhouse gas (GHG) emissions. In Japan, healthcare accounts for approximately 5% of GHG emissions estimated based on economic costs. In the medical sector, pharmaceuticals account for a large proportion of these emissions. GHG produced during...
Autor principal: | Nagai, Kei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Japan Medical Association
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10628314/ https://www.ncbi.nlm.nih.gov/pubmed/37941697 http://dx.doi.org/10.31662/jmaj.2023-0026 |
Ejemplares similares
-
Recent Debate over How to Tackle Rapid Increases in Pharmaceutical Expenditure in Japan
por: Niki, Ryu
Publicado: (2020) -
Training bacteria to produce environmentally friendly polymers of industrial and medical relevance
por: Huertas, María José, et al.
Publicado: (2019) -
Towards the elimination of cervical cancer in Japan
por: Hanley, Sharon J.B.
Publicado: (2021) -
Building the Momentum for A Stronger Pharmaceutical System in Africa
por: Ussai, Silvia, et al.
Publicado: (2022) -
Are we really “screening” movement? The role of assessing movement quality in exercise settings
por: Bennett, Hunter, et al.
Publicado: (2020)